European Commission
The constellation of challenges to implementing the IVDR by next year have prompted players to openly call for its postponement and phased implementation.
Illumina Challenges European Commission's Jurisdiction Over Review of Grail Acquisition in EU General Court
Illumina continues to fight against European regulators who want the European Commission to review the deal under untested legal mechanisms.
European Union to Review Illumina's Planned Grail Acquisition Under New Guidance
Illumina reaffirmed its commitment to the $8 billion deal and said it does not believe the European authorities have jurisdiction to review it.
European Consortium Seeks to Develop Liquid Biopsy Test for Prostate, Testicular Cancer
The European Commission awarded a consortium of private companies and academic researchers €759,000 recently to carry out their plans.
Israeli Diagnostics Firm NanoSynex Aiming for European Market Entry for AMR Test by 2023
The European Commission recently awarded the company a two-year, €2.6 million Horizon 2020 grant to achieve its ambitions.
Dec 13, 2019
EU Group Issues New IVD Guidelines
Dec 10, 2019